Esophageal cancer (EC) is a disease often marked by aggressive growth and poor
prognosis. Lack of targeted therapies, resistance to chemoradiation therapy, and distant …

PURPOSE Preoperative chemoradiotherapy according to the chemoradiotherapy for
esophageal cancer followed by surgery study (CROSS) has become a standard of care for …

Simple Summary The aim of this review was to describe the rationale for immunotherapy in
different stages of esophageal cancer (EC) treatment, with a particular accent on curative …

Perioperative chemotherapy with 5‐fluorouracil, leucovorin, oxaliplatin and docetaxel
(FLOT) is a mainstay in the treatment of esophagogastric adenocarcinomas (EGA) …

PURPOSE High pathologic complete response (pCR) rates and comparably good survival
data were seen in a phase II trial combining perioperative fluorouracil, leucovorin …

Chemoradiotherapy is a widely used treatment for patients with malignancies such as
hepatocellular carcinoma (HCC). However, it remains challenging to realize safe and …

X‐rays are rays that penetrate the human tissue and are capable of penetrating water, air,
and oxygen in various biological tissues or tumors. In recent years, significant progress has …

HER2 is highly expressed in a variety of malignant tumors and affects the prognosis of
patients, making it a highly sensitive target for cancer therapy. Since the approval of the first …

Esophageal cancer is one of the most lethal cancers worldwide because of its rapid
progression and poor prognosis. Esophageal squamous cell carcinoma (ESCC) and …

Background With increasing interest in organ-preserving strategies for potentially curable
esophageal cancer, real-world data is needed to understand the impact of pathological …